USA
- USA
- CHN
- DEU
- FRA
- JPN
- KOR
- UK

Insights

Title Date Associated Professionals
What Drug Companies Should Be Thinking About After the U.S. - China Trade Deal 1/23/2020 By Melanie Rupert, Mi Zhou & Jake Silvers
What Asset Managers Need to Know—and Do—About the SEC’s Recent Focus on Impact Investment Strategies 1/7/2020 By Vadim Avdeychik
Department of Labor Issues Major Update to FLSA Regulations Governing the Regular Rate of Pay 12/20/2019 By Zach Hutton
How to Think About and Successfully Navigate Patent Eligibility After Alice, Myriad, and Mayo 12/17/2019 Bruce Wexler, Yar Chaikovsky, Mi Zhou & Joshua Yin
SEC Proposes to Modernize Regulation of the Use of Derivatives by Registered Investment Companies 12/9/2019 By The Investment Management Practice
Plx Likely Stands On Its Own, But Has Room To Grow 11/26/2019 By Barry A. Brooks, Jordan L. Goldman, Joseph P. DiCarlo & Matthew R. Schob
The SEC Clears the Path for Investors as Potential Whistleblowers: Greater Scrutiny May Be on the Horizon During Regulatory Examinations 11/21/2019 Ira Kustin, John P. Nowak, Michael Spafford, Amanda Pober & Daren Stanaway
New York State Human Rights Law: Changes to Know 11/19/2019 Marc E. Bernstein, Kenneth W. Gage, Emily R. Pidot, Patrick W. Shea, Brian M. Hayes & Adriana N. Simmons

Pages: 1 2 3 4 5 Next > Show All